Cannabis Suisse Corp
CSUI
$0.00530 0.00%
Exchange: OTC | Sector: Healthcare | Industry: Drug Manufacturers Specialty Generic
Q2 2025
Published: Jan 13, 2025

Earnings Highlights

  • Revenue of $0.01M up 0% year-over-year
  • Gross margin of 1.9%
  • Net income of 5.06K
  • "" -
CSUI
Company CSUI

Executive Summary

Cannabis Suisse Corp (CSUI) reported a flat revenue profile for QQ2 2025, with quarterly revenue of $7,500 and a minimal gross profit of $144 (gross margin 1.92%). The quarter’s profitability was dominated by a substantial GAAP operating expense load of $91,392, yielding an operating loss of $91,248 and an EBITDA of βˆ’$91,248 (EBITDA margin βˆ’12.17%). Net income of $5,062 appears to reflect a non-operating income item of $96,310, which temporarily conceals the deteriorating core earnings profile. On a cash-flow basis, operating cash flow was negative at $(19,142), and free cash flow was also $(19,142), with the cash balance ending at $4,100 versus $25,742 at the start of the period, underscoring a liquidity constraint.

Key Performance Indicators

Revenue
Stable
7.50K
QoQ: 0.00% | YoY: 0.00%
Gross Profit
Decreasing
144.00
1.92% margin
QoQ: 0.00% | YoY: -77.00%
Operating Income
Decreasing
-91.25K
QoQ: -21.93% | YoY: -79.97%
Net Income
Increasing
5.06K
QoQ: 100.95% | YoY: 109.24%
EPS
Increasing
0.00
QoQ: 101.32% | YoY: 108.33%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q3 2025 0.01 0.00 +0.0% View
Q2 2025 0.01 0.00 +0.0% View
Q1 2025 0.01 -0.01 +0.0% View
Q4 2024 0.01 -0.02 +0.0% View
Q3 2024 0.01 0.00 +200.0% View